These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The F-box protein SKP2 mediates androgen control of p27 stability in LNCaP human prostate cancer cells. Lu L; Schulz H; Wolf DA BMC Cell Biol; 2002 Aug; 3():22. PubMed ID: 12188931 [TBL] [Abstract][Full Text] [Related]
4. Fatty Acid Synthase Promotes Hepatocellular Carcinoma Growth via S-Phase Kinase-Associated Protein 2/p27 Cigliano A; Simile MM; Vidili G; Pes GM; Dore MP; Urigo F; Cossu E; Che L; Feo C; Steinmann SM; Ribback S; Pascale RM; Evert M; Chen X; Calvisi DF Medicina (Kaunas); 2024 Jul; 60(7):. PubMed ID: 39064589 [No Abstract] [Full Text] [Related]
5. The amelioration of renal damage in Skp2-deficient mice canceled by p27 Kip1 deficiency in Skp2-/- p27-/- mice. Suzuki S; Fukasawa H; Misaki T; Togawa A; Ohashi N; Kitagawa K; Kotake Y; Liu N; Niida H; Nakayama K; Nakayama KI; Yamamoto T; Kitagawa M PLoS One; 2012; 7(4):e36249. PubMed ID: 22558406 [TBL] [Abstract][Full Text] [Related]
6. C-terminal phosphorylation controls the stability and function of p27kip1. Kossatz U; Vervoorts J; Nickeleit I; Sundberg HA; Arthur JS; Manns MP; Malek NP EMBO J; 2006 Nov; 25(21):5159-70. PubMed ID: 17053782 [TBL] [Abstract][Full Text] [Related]
11. miR-221/222 compensates for Skp2-mediated p27 degradation and is a primary target of cell cycle regulation by prostacyclin and cAMP. Castagnino P; Kothapalli D; Hawthorne EA; Liu SL; Xu T; Rao S; Yung Y; Assoian RK PLoS One; 2013; 8(2):e56140. PubMed ID: 23409140 [TBL] [Abstract][Full Text] [Related]
12. Testing the importance of p27 degradation by the SCFskp2 pathway in murine models of lung and colon cancer. Timmerbeul I; Garrett-Engele CM; Kossatz U; Chen X; Firpo E; Grünwald V; Kamino K; Wilkens L; Lehmann U; Buer J; Geffers R; Kubicka S; Manns MP; Porter PL; Roberts JM; Malek NP Proc Natl Acad Sci U S A; 2006 Sep; 103(38):14009-14. PubMed ID: 16966613 [TBL] [Abstract][Full Text] [Related]
13. The interaction of SKP2 with p27 enhances the progression and stemness of osteosarcoma. Wang J; Aldahamsheh O; Ferrena A; Borjihan H; Singla A; Yaguare S; Singh S; Viscarret V; Tingling J; Zi X; Lo Y; Gorlick R; Zheng D; Schwartz EL; Zhao H; Yang R; Geller DS; Hoang BH Ann N Y Acad Sci; 2021 Apr; 1490(1):90-104. PubMed ID: 33594717 [TBL] [Abstract][Full Text] [Related]
14. p27(Kip1)is overexpressed in very early stages of hepatocarcinogenesis. Yachida S; Sakamoto M; Imaida K; Yokohira M; Saoo K; Okano K; Wakabayashi H; Maeta H; Suzuki Y Cancer Sci; 2008 Nov; 99(11):2152-9. PubMed ID: 18808421 [TBL] [Abstract][Full Text] [Related]
15. Enzyme-independent role of EZH2 in regulating cell cycle progression via the SKP2-KIP/CIP pathway. Colon T; Kou Z; Choi BH; Tran F; Zheng E; Dai W Sci Rep; 2024 Jun; 14(1):13389. PubMed ID: 38862595 [TBL] [Abstract][Full Text] [Related]
16. Skp2-dependent degradation of p27kip1 is essential for cell cycle progression. Kossatz U; Dietrich N; Zender L; Buer J; Manns MP; Malek NP Genes Dev; 2004 Nov; 18(21):2602-7. PubMed ID: 15520280 [TBL] [Abstract][Full Text] [Related]
17. A novel mutation in β integrin reveals an integrin-mediated interaction between the extracellular matrix and cki-1/p27KIP1. Kihira S; Yu EJ; Cunningham J; Cram EJ; Lee M PLoS One; 2012; 7(8):e42425. PubMed ID: 22879977 [TBL] [Abstract][Full Text] [Related]
18. Fbxw7 and Skp2 Regulate Stem Cell Switch between Quiescence and Mitotic Division in Lung Adenocarcinoma. Zhang W; Ren Z; Jia L; Li X; Jia X; Han Y Biomed Res Int; 2019; 2019():9648269. PubMed ID: 31534970 [TBL] [Abstract][Full Text] [Related]
19. AML1/RUNX1 phosphorylation by cyclin-dependent kinases regulates the degradation of AML1/RUNX1 by the anaphase-promoting complex. Biggs JR; Peterson LF; Zhang Y; Kraft AS; Zhang DE Mol Cell Biol; 2006 Oct; 26(20):7420-9. PubMed ID: 17015473 [TBL] [Abstract][Full Text] [Related]
20. The SKP2-p27 axis defines susceptibility to cell death upon CHK1 inhibition. Lohmüller M; Roeck BF; Szabo TG; Schapfl MA; Pegka F; Herzog S; Villunger A; Schuler F Mol Oncol; 2022 Aug; 16(15):2771-2787. PubMed ID: 35673965 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]